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We tested the hypothesis that the connection between advanced maternal age and autosomal trisomy reflects the
diminution of the oocyte pool with age. Because menopause occurs when the number of oocytes falls below some
threshold, our hypothesis is that menopause occurs at an earlier age among women with trisomic pregnancies than
it does among women with chromosomally normal pregnancies. To determine their menstrual status, we interviewed
women from our previous study of karyotyped spontaneous abortions who, in 1993, were age 44 years. Pre-
menopausal women completed interviews every 4–5 mo, until menopause or until the study ended in 1997. The
primary analyses compare 111 women whose index pregnancy was a trisomic spontaneous abortion with two
groups: women whose index pregnancy was a chromosomally normal loss ( ) and women whose indexn = 157
pregnancy was a chromosomally normal birth ( ). We used a parametric logistic survival analysis to comparen = 226
median ages at menopause. The estimated median age at menopause was 0.96 years earlier (95% confidence interval
50.18 to 2.10) among women with trisomic losses than it was among women with chromosomally normal losses
and chromosomally normal births combined. Results were unaltered by adjustment for education, ethnicity, and
cigarette smoking. Our results support the hypothesis that trisomy risk is increased with decreased numbers of
oocytes. Decreased numbers may indicate accelerated oocyte atresia or fewer oocytes formed during fetal
development.
Introduction
This study seeks to elucidate the well-established asso-
ciation of advancing maternal age with autosomal tri-
somy (Kline et al. 1989). At least 3% of clinically rec-
ognized pregnancies are trisomies; 190% end in spon-
taneous abortion (Kline et al. 1989). Both the few tri-
somies that are compatible with survival to birth (pri-
marily trisomies 13, 18, and 21 [Down syndrome]) and
the majority of autosomal trisomies that end in spon-
taneous abortion increase in frequency with maternal
age (Hassold and Chiu 1985; Risch et al. 1986). In most
autosomal trisomies, the extra chromosome is of ma-
ternal origin; almost all are due to errors duringmaternal
meiosis I (Koehler et al. 1996; Lamb et al. 1996, 1997).
It seems reasonable to infer that trisomy results from
physiological processes that are intimately tied to chron-
ological age. One candidate process is the decline in the
size of the ovarian oocyte pool with age. The germ-cell
population is largest (∼7 million) during fetal develop-
ment and decreases approximately exponentially with
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chronological age (Block 1952; Baker 1963; Thom-
ford et al. 1987; Faddy et al. 1992). Within this overall
pattern, at any given chronological age, follicle counts
vary among women (Block 1952; Faddy et al. 1992;
Reuss et al. 1996). Variability may reflect differences
either in the number of oocytes laid down or in rates
of atresia, each potentially influenced by endogenous or
exogenous factors.
We hypothesized that the association of chronological
age with trisomy reflects an association between the
number of oocytes and trisomy, with trisomy risk higher
in women with fewer oocytes (Warburton 1989; Kline
and Levin 1992). Since menopause occurs when the
number of follicles falls below some threshold (Kline
and Levin 1992), our hypothesis is that menopause oc-
curs earlier in women who have had trisomic pregnan-
cies than in women who have had chromosomally nor-
mal pregnancies (whether losses or births).
Subjects and Methods
Participants
Subjects were from a follow-up investigation of
women who had participated, during 1974–86, in a
New York City hospital–based case-control study of
spontaneous abortions (Kline et al. 1995). Beginning in
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Table 1
Selected Characteristics of the Sample
TRISOMIC LOSS
CHROMOSOMALLY NORMAL
Loss Live Birth
No. of women in sample 150 209 264
No. (%) interviewed a 120 (80.0) 168 (80.4) 236 (89.4)
No. excluded because of subsequent trisomy 0 0 2
Eligible women, from intake interview:
No. 120 168 234
Mean age (SD [years]):b
At index pregnancy 36.1 (4.0) 34.3 (3.9) 34.5 (3.8)
At intake 49.3 (3.8) 49.2 (3.4) 48.4 (3.1)
Ethnicity (%): b
White, non-Hispanic 80.0 69.0 77.8
Black, non-Hispanic 5.8 16.1 6.0
Other 14.2 14.9 16.2
Born in the United States (%) 75.8 73.2 70.9
Education (%): b,c
Some high school or high school graduate 8.3 16.7 15.0
Some college 15.0 20.2 22.6
College graduate 19.2 29.8 23.9
Postgraduate 57.5 33.3 38.5
Mean no. (SD) of births 1.8 (1.2) 2.0 (2.7) 2.5 (1.3)
Mean no. (SD) of spontaneous abortions 1.8 (1.1) 2.4 (1.7) .6 (.9)
Mean no. (SD) of induced abortions .4 (.8) .5 (.9) .4 (.9)
Cigarette smoking (%):
Never smoked 53.3 52.4 52.6
Ex-smoker 39.2 35.7 36.2
Current smoker 7.5 11.9 11.1
No. with menopause at intaked 31 38 46
No. eligible for follow-up: 89 130 188
Completed at least one follow-up interview 82 (92.1) 125 (96.2) 184 (97.9)
Menopause at end of follow-up 21 38 46
a Of the 99 women not interviewed, 83 refused participation, 10 could not be located, and 6 were either deceased
or too ill for interview.
b Age at index pregnancy, age at intake interview, ethnicity, and education are each independently associated
( ) with outcome of the index pregnancy.P ! .05
c For 478 women, education at the time of the intake interview; for 44 women who completed a short version
of the intake interview, education at the time of the earlier case-control study.
d Includes women with natural menopause, surgical menopause, and menopause while taking hormones.
January 1993, we attempted to enroll private patients
(i.e., patients of private physicians), age 44 years,
whose index spontaneous abortion was trisomic (n =
) or chromosomally normal ) and a sample150 (n = 209
of the original control group who had chromosomally
normal live births ( ). To achieve comparabilityn = 264
in age at follow-up, we selected, from the original live-
birth control group, all women born during 1933–42
(i.e., women 51–60 years of age) and 50% of women
born in each 2-year birth interval from January 1943 to
July 1949 (i.e., women 44-50 years of age). Both chro-
mosomally normal comparison groups excluded women
with prior known trisomic pregnancies. The study was
approved by our institutional review board.
The intake interview was completed by 524 (84%)
women; analyses excluded 2 women in the live-birth
cohort who had subsequent trisomic pregnancies (table
1). Interview rates for the trisomy, chromosomally nor-
mal loss, and live-birth cohorts were 80%, 80%, and
89%, respectively. Interview rates were higher for
women born in the United States, although this factor
did not explain the lower interview rates among women
with losses. Interview rates did not vary independently
with age at follow-up, year of entrance into the original
study, obstetric history, ethnicity, or marital status.
At intake, women completed a telephone interview
that included questions about menses, obstetric and gy-
necologic histories, hormonal medications, and common
exposures. We attempted to follow, at 4-mo intervals,
the 407 women who either were still menstruating (i.e.,
who had had at least one menstrual period during the
previous year) or were bleeding while taking hormones.
(We distinguish “menstruation” from “bleeding on hor-
mones,” because hormones can induce bleeding after the
age when menopause would have occurred.) Follow-up
ended either when a woman reachedmenopause (natural
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or surgical) or with termination of the study in Novem-
ber 1997.
To minimize opportunities for differential ascertain-
ment of menstrual or other data, interviewers obtained
the obstetric history at the end of the intake interview.
Follow-up interviews were conducted by an interviewer
other than the intake interviewer. Interviewers did not
know the study hypothesis.
Comparability of the Three Groups
Mean age at the index pregnancy for the trisomy co-
hort was ∼1.7 years later than that for either comparison
group; mean age at follow-up for the trisomy cohort
was similar to that for the chromosomally normal–loss
cohort and 0.9 years later than that for the live-birth
cohort (table 1). The cohorts differed in ethnicity and
education but not in place of birth. Rates of cigarette
smoking—the only exposure consistently associated
with age at menopause—did not differ. As expected,
since the sample consisted of women identified at the
time of a previous pregnancy, prior spontaneous abor-
tions were higher among women whose index pregnancy
was a loss; parity was higher among womenwhose index
pregnancy was a live birth.
Menstrual Status
At intake, we asked each woman whether she had had
a menstrual period in the past 12 mo and, if so, the date.
We also asked whether, in the month before her last
period, she had taken estrogen, oral contraceptives, or
other medications that affect periods and, if so, the date
of the period before she began the medication. Women
were asked about their use of estrogen for menopausal
symptoms or prevention of diseases such as bone loss
and about surgery involving removal of the uterus, ova-
ries, or fallopian tubes. At each follow-up interview, we
obtained similar information.
In keeping with convention, we classified as naturally
menopausal women who went through 12 mo without
menstruating (or bleeding on hormones) in the absence
of known causes of amenorrhea—surgical removal of
the uterus or ovaries ( ) and chemotherapy or ra-n = 43
diotherapy ( ). These events, as well as the use ofn = 8
hormones that induce bleeding, prevent observing age
at natural menopause. The primary analyses drew on
interview data until the occurrence of such a censoring
event.
Before reaching menopause, 121 (23%) women used
either estrogen with or without progesterone ( ),n = 107
oral contraceptives ( ), or both ( ). The ma-n = 10 n = 4
jority of women began hormone use before experiencing
a lengthy episode of amenorrhea; 48 women discontin-
ued use at least once, and, among them, 32 resumed
menstruating. Our analyses censored observations at the
interview in which the woman’s last menstrual period
(LMP) occurred. (We use “LMP” to refer to bleeding in
the absence of estrogen or oral contraceptive use.) For
example, for women who began hormone use in the year
before the intake interview and who continued use, ob-
servations were censored at the intake interview; for
women who began hormone use after intake and who
continued use, observations were censored at the inter-
view in which hormone use began; and, for women who
stopped taking hormones and who resumed menstru-
ating, we drew on observations until the last informative
interview. The primary analyses excluded 28 “uninform-
ative” women who began taking hormones before reach-
ing menopause and whose LMP occurred 11 year before
the intake interview.
An additional 24 women used other hormonal med-
ications. Most took progesterone only ( ) or “un-n = 16
known” medications for indications for which proges-
terone is commonly prescribed ( ). Since it is unlikelyn = 4
that progesterone alters the timing of natural meno-
pause, we treated bleeding episodes on progesterone as
menstrual periods. Of the remaining four “other-medi-
cation” users, three resumed menstruating after use and
one had a hysterectomy. In summary, the end of obser-
vation was defined by either natural menopause or one
of four possible censoring events: surgical menopause,
estrogen or oral contraceptive use, amenorrhea induced
by chemotherapy or radiotherapy, or the last study
interview.
Analysis
We used a parametric logistic survival analysis to test
differences in the distributions of age at menopause; in
particular, we compared median age at menopause of
the trisomy cohort with that of the chromosomally nor-
mal cohorts, both separately and combined.
Our analysis combined information from both the
cross-sectional data obtained at the intake interview and
the prospective data obtained at follow-up interviews.
The two types of data provide different degrees of pre-
cision as to the date of the LMP for women who reached
natural menopause. Retrospective reports of age at nat-
ural menopause, like those obtained at intake, are sub-
ject to error (MacMahon andWorcester 1966). To avoid
imprecision, we used, for intake data, only information
on the exact age at interview and on menstrual status
(reached natural menopause vs. menstruating). For
women who had not reached menopause at intake, we
used the more precise information provided by the date
of LMP.
To model age at ascertained menopause (LMP  12
mo), we used a logistic cumulative incidence function
(MacMahon and Worcester 1966; Brambilla and Mc-
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Kinlay 1989). In this analysis, the term “left-censoring”
means that the only information known (or used) is that
natural menopause occurred before (“to the left of”) the
beginning of observation. The term “right-censoring”
means that the only information known is that natural
menopause would occur after (“to the right of”) the end
of observation. In our logistic survival analysis, women
who were already menopausal at intake enter the like-
lihood function as left-censored observations as of their
age at intake. Women who reached natural menopause
during follow-up entered the likelihood function as ob-
served events at their exact age at ascertained meno-
pause. Women with surgical menopause were right-cen-
sored either as of their age at surgery (if before intake)
or at LMP  12 mo (if during follow-up). Women who
did not reach natural menopause by the end of obser-
vation were right-censored; we defined age at the end of
observation as age at LMP 12 mo since, by definition,
ascertained menopause could not have occurred before
this time.
Let T denote age at ascertained natural menopause.
For women entering the study who already were men-
opausal at age t, a factor is entered into the likelihood
of P [T ! t] = exp {v  v (t 50)} / [1 exp {v  v (t1 2 1 2
, where v1 and v2 are intercept and slope parameters,50)}]
respectively, of the logistic model; v1 is the log odds on
ascertained menopause at age !50 years versus age
150 years. For observations that are right-censored at
age t, the likelihood factor is P [T 1 t] = 1 P [T ! t] =
. For observed menopause1/ [1 exp {v  v (t 50)}]1 2
events at age T = t, the likelihood factor is the logis-
tic density function, f(t) = v exp {v  v (t 50)} / [12 1 2
. The logistic hazard function is2exp {v  v (t 50)}]1 2
. v2 can be interpreted as thef(t)/P [T 1 t] = v P [T ! t]2
maximum hazard for menopause over a woman’s life-
time. The likelihood function is the product of one of
the above three expressions for each woman. To check
the validity of the model, we compared the model-based
survival function with a nonparametric maximum like-
lihood estimate (Turnbull 1976) accounting for the pres-
ence of left and right censoring. The fit was excellent.
The median age at ascertained menopause in this
model is . We estimated median-age differ-50 v /v1 2
ences between the trisomy cohort and the two compar-
ison groups by specifying linear models for v1 and log
v2. Where these shifts are similar, we calculated a
weighted average of the maximum likelihood estimates
of the two shifts, with weights chosen to minimize the
variance of the combined estimate.
Education and ethnicity differed between the cohorts,
and each was associated with age at menopause (see
table 3, footnote b); cigarette smoking was associated,
albeit not significantly, with earlier age at menopause.
We present both unadjusted and adjusted estimates of
the shifts in median age at natural menopause.
To examine the effect of treating hormone use as a
censoring event, we undertook four sensitivity analyses.
Results were similar when we classified (1) the unin-
formative women as naturally menopausal; (2) the un-
informative women as still menstruating; (3) the unin-
formative women plus current hormone users (women
whose observations were censored by hormone use;
) as naturally menopausal; and (4) the uninform-n = 51
ative women plus long-term hormone users (1 years;
) as naturally menopausal.n = 40
We also tested two subsidiary predictions. First, on
the basis of our mathematical model relating age to the
number of ovarian oocytes, trisomy risk, and meno-
pause, we predicted that the magnitude of the shift to-
ward earlier menopause would be larger for womenwith
trisomic pregnancies at age 34 years than for younger
women (Kline and Levin 1992). Second, we predicted
that shifts toward earlier menopause would be largest
for women with trisomic pregnancies whose mean ma-
ternal age is highest—that is, the double trisomies and
trisomies of the smaller chromosomes (Hassold and
Chiu 1985; Warburton et al. 1986).
Results
Natural menopause had been reached, by the end of the
study, by 35% of women with trisomic losses, 29% of
women with chromosomally normal losses, and 29% of
women with live births (table 2). The primary analyses
draw on women who were informative at intake: 111
with trisomic losses, 157 with chromosomally normal
losses, and 226 with live births.
Age at natural menopause occurred earlier in the tri-
somy cohort (table 3). Without adjustment for covar-
iates, the estimated median age at ascertained meno-
pause was 53.4 years for the trisomy cohort, 54.2 years
for the chromosomally normal–loss cohort, and 54.4
years for the live-birth cohort. When evidence from the
two comparison groups were combined, the estimated
median age at menopause occurred 0.96 years earlier
in the trisomy cohort than in the chromosomally normal
cohorts (95% confidence interval [CI] 0.18 to 2.10).
Estimated shifts were essentially unaltered by adjust-
ment for education, ethnicity, and cigarette smoking
(shift = 1.02 years). The cumulative-incidence curve for
age at ascertained menopause, obtained from the par-
ametric logistic model, fit the data well (fig. 1). There
were no statistically significant differences, in the slopes
(v2) of the cumulative-incidence function, between the
trisomy cohort and the two comparison groups, nor
were there differences related to the covariates.
We repeated the analyses to examine the sensitivity
of the results to treatment of hormone use as a censoring
event and to the exclusion of uninformative women.
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Table 2
Menopause Status and Estrogen/Oral Contraceptive Use Prior to Menopause in Women with Trisomic Losses,
Chromosomally Normal Losses, and Live Births: Last Informative Interview
NO. (%) OF WOMEN WITH
Trisomic Loss
Chromosomally Normal
Loss Live Birth
Natural menopause at intakea 27 (22.5) 25 (14.9) 32 (13.7)
Natural menopause during follow-upa 15 (12.5) 24 (14.3) 36 (15.4)
Surgical menopause at intake 4 (3.3) 13 (7.7) 13 (5.6)
Surgical menopause during follow-up 0 (.0) 8 (4.8) 5 (2.1)
Menstrual period in the past year:
No current hormone use b 54 (45.0) 75 (44.6) 111 (47.4)
Current hormone use b 11 (9.2) 12 (7.1) 29 (12.4)
Uninformative at intake c 9 (7.5) 11 (6.5) 8 (3.4)
Total 120 168 234
NOTE.—The last informative interview is defined by either natural menopause or one of four possible censoring events:
surgical menopause, estrogen or oral contraceptive use, amenorrhea induced by chemotherapy or radiotherapy, or the
last study interview. Because of censoring, fewer women are classified as naturally or surgically menopausal on the basis
of data from the last informative interview ( ) rather than on the basis of data drawing on all observations (n = 202 n =
; table 1).220
a Includes 8 women (5 at intake, 3 during follow-up) who used premenopausal hormones and reached menopause.
b Premenopausal hormone use includes estrogen and oral contraceptives. We define as “current” hormone users those
women whose observations are censored because of premenopausal hormone use.
c The women’s LMP was 11 year before the interview, and they had begun hormone use before menopause occurred.
We were thus unable to observe natural menopause.
Three of the four sensitivity analyses yielded estimates
of 10.96 years. The estimated shift between the trisomy
cohort and the two comparison groups combined was
smallest when uninformative women were classified as
menstruating at intake (unadjusted shift = 0.78; 95%
CI 0.38 to 1.93) and largest when uninformative
women were classified as having reached menopause at
intake (unadjusted shift = 1.19; 95% CI 0.04–2.34).
The magnitude of the shifts toward earlier menopause
did not vary significantly with age at index pregnancy.
Estimated shifts for women with index pregnancies at
age !34 years and at age34 years were 1.34 and 0.69,
respectively (table 4).
Median age at menopause tended to be earlier for all
trisomy groups except those with trisomies 6–12. Men-
opause occurred earlier, by an estimated 2.39 years, for
double trisomies; 1.63 years for trisomies 13–15, 17,
and 18; and 1.47 years for trisomies 20–22 (table 4).
Data were too sparse either to test associations with
trisomies of each chromosome separately or to test
whether associations with trisomy group varied with
age at index pregnancy.
Discussion
The hypothesis that the connection between advancing
maternal age and autosomal trisomy reflects the dimi-
nution of the oocyte pool predicts that menopause will
occur earlier in women with trisomic pregnancies. Our
data support the hypothesis: median age at menopause
is ∼1 year earlier among women with trisomic sponta-
neous abortions than that among women with chro-
mosomally normal pregnancies. Estimated shifts in age
at menopause were essentially the same with and with-
out adjustment for education, ethnicity, or cigarette
smoking.
Strictly speaking, we cannot exclude, at the 5% level
of significance, using a two-tailed test, the null hy-
pothesis of no difference (95% CI 0.18 to 2.10; P =
). Nevertheless, we do not “accept” the null hy-.097
pothesis, for several reasons. (1) The scientific hypoth-
esis was a priori and predicted the direction and effect
size observed. (2) Associations were consistent: com-
parisons with both the chromosomally normal–loss co-
hort, who derived from the same sample as the trisomy
cohort, and the live-birth cohort yielded similar esti-
mates of the shift in age at menopause (0.87 and 1.03
years, respectively). (3) Associations were robust, al-
tered only slightly by different analytic approaches for
women who began using estrogen or oral contraceptives
prior to reaching menopause; estimated shifts had a
range of 0.78–1.19 years, depending on assumptions
about the relation between premenopausal hormone use
and true “unobserved” menopause status. Our primary
analysis yields an estimate in the middle of this range.
Overall, among women with chromosomally normal
pregnancies, estimated median age at LMP was ∼53.3
years, which is ∼2 years later than estimates from a
similar study done in the early 1980s (McKinlay et al.
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Table 3
Age at Ascertained Natural Menopause in Women with Trisomic Losses Compared with Women with Chromosomally Normal Losses and
Those with Live Births: Median Ages and Shifts in Median Ages
NO. OF
WOMENa
MEDIAN AGE (SE)
(years)
SHIFT IN MEDIAN AGE (95%CI), COMPARING
WOMEN WITH CHROMOSOMALLY NORMAL
PREGNANCIES AND THOSE WITH TRISOMIC PREGNANCIES
(years)
Unadjusted Adjusted b
Trisomic loss 111 53.36 (.52)
Chromosomally normal loss 157 54.22 (.46) .87 (.43 to 2.17) .92 (.40 to 2.24)
Chromosomally normal live birth 228 54.38 (.40) 1.03 (.20 to 2.26) 1.07 (.13 to 2.28)
Chromosomally normal combinedc .96 (.18 to 2.10) 1.02 (.11 to 2.14)
a Excludes 28 women whose data were uninformative because they began premenopausal hormone use 11 year before the intake interview.
b Adjusted for influence of education (some high school or high school graduate, some college, college graduate, postgraduate), ethnicity
(white non-Hispanic, black non-Hispanic, other) and cigarette smoking (current smoker, ex-smoker, never smoked) on v1 (the log odds on
ascertained menopause at age !50 years vs. age 150 years). These covariates were not significantly associated with log v2, the slope coefficient.
Education was associated with v1 ( ), although the pattern was not monotonic; median age at menopause was later for college graduatesP = .02
than for postgraduates. Ethnicity was associated with v1 ( ); median age at menopause was ealier for “other” ethnicity and black non-P = .02
Hispanic than for white non-Hispanic. Cigarette smoking was not significantly associated with v1 ( ); median age at menopause tendedP = .29
to be earlier in ex-smokers and current smokers than in those who had never smoked.
c Median age at ascertained menopause was not estimated for the two comparison groups combined. The estimate for the difference between
the trisomy cohort and the two chromosomally normal cohorts combined was obtained by taking a weighted average of the individual shifts.
1985; Brambilla and McKinlay 1989). The difference
in age is not unreasonable, however, because the prev-
alence of current cigarette smoking in our sample was
much lower (11%, vs. 39% in McKinlay et al. 1985).
Four studies report age at menopause of women with
children who have Down syndrome (Oster 1953; Smith
and Record 1955; Sigler et al. 1967; Phillips et al. 1995).
Interpretation of these studies is undermined by impre-
cise definitions of menopause; indeed, two reports (Os-
ter 1953; Smith and Record 1955) classified some
women as menopausal before the trisomic pregnancy.
One study (Sigler et al. 1967) had the advantage of an
age-matched comparison group and follow-up some
years after the birth of the child; the direction of results
is consistent with our hypothesis. The most recent study
(Phillips et al. 1995) was deemed not to support the
hypothesized shift in age at menopause; unfortunately,
interpretation is hindered by methodological limitations
(e.g., controls were selected only for cases that had
reached menopause).
Our ovarian-aging hypothesis stems, in part, from the
work of Brook et al. (1984). Chronological age was
separated from physiological reproductive age by com-
parison of mice with unilateral oophorectomy to age-
matched sham-operated mice. Oophorectomized mice
had a higher rate of chromosomal anomalies and earlier
onset of estrous acyclicity (Brook et al. 1984), thus im-
plicating the size of the oocyte pool in the occurrence
of nondisjunction. Results from a case-control study of
women with trisomy 21 pregnancies, although impre-
cise because of the rarity of oophorectomy, are com-
patible with those in mice: surgical removal of part or
all of an ovary was reported more often for cases than
for controls (Freeman et al. 2000).
As women age, the decline in the size of the total
oocyte pool is accompanied by a decline in the number
of antral follicles that mature during each menstrual
cycle (Peters and McNatty 1980). Mechanisms related
to nondisjunction could, in theory, operate at any time
between the formation of the oocyte pool (when the
woman herself is in utero and meiosis I begins) and the
completion of meiosis I at ovulation. Two studies im-
plicate factors occurring around the time of oocyte mat-
uration rather than around the time of ovulation (Vo-
larcik et al. 1998). Rates of nondisjunction were ob-
served in preovulatory oocytes—retrieved from either
natural (Volarcik et al. 1998) or hormone-stimulated
cycles (Battaglia et al. 1996)—and were induced to com-
plete meiosis I in vitro. Nondisjunction occurred more
often in oocytes retrieved from older women than in
those from younger women. Among the mechanisms
hypothesized to operate in the aging ovary are defects
in oocyte maturation (Volarcik et al. 1998), a change
in the hormonal milieu (Brook et al. 1984; Eichenlaub-
Ritter 1996), and a change in the levels of proteins that
influence proper chromosome segregation (Koehler et
al. 1996). These mechanisms, in turn, might be influ-
enced either by the size of the underlying oocyte pool
or by the number of maturing follicles. For example,
levels of circulating follicle-stimulating hormone (Reyes
et al. 1977; Metcalf and Livesay 1985; Lee et al. 1988;
Lenton et al. 1988; MacNaughton et al. 1992) and in-
hibin B (Klein et al. 1996) change during the repro-
ductive years. It is not yet clear, however, whether
Figure 1 Comparison of cumulative incidence of ascertained menopause, from nonparametric maximum likelihood estimate (Turnbull 1976) and logistic survival model, in women with trisomic
losses (a), chromosomally normal losses (b), and chromosomally normal live births (c). Comparison of cumulative incidence estimates for the three groups (d) also is shown.
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Table 4
Estimated Shifts in Median Age at Ascertained Natural Menopause in Women with Trisomic Losses, Classified by Age at Index
Pregnancy and Type of Trisomy, Compared with Women with Chromosomally Normal Losses and Those with Live Births
NO. OF
WOMENb
NO. REACHING
MENOPAUSE
SHIFT IN MEDIAN AGE (95% CI), COMPARING
WOMEN WITH CHROMOSOMALLY NORMAL
PREGNANCIES (LOSSES AND LIVE BIRTHS)
AND THOSE WITH TRISOMIC PREGNANCIESa
Unadjusted Adjustedc
Age at index pregnancy = 27–33 years:
Trisomic loss 28 4 1.34 (2.60 to 5.28) 1.17 (2.90 to 5.24)
Chromosomally normal loss 73 9
Chromosomally normal live birth 83 12
Age at index pregnancy = 34–46 years:
Trisomic Loss 83 38 .69 (.53 to 1.92) .82 (.37 to 2.01)
Chromosomally normal loss 84 40
Chromosomally normal live birth 143 56
Trisomy type:
1–5 9 3 .48 (3.65 to 4.60) .97 (2.96 to 4.90)
6–12 14 2 3.45 (7.33 to .43) 3.67 (7.56 to .22)
13–15, 17, 18 28 15 1.63 (.19 to 3.45) 1.91 (.14 to 3.68)
16 25 6 .87 (1.50 to 3.24) .84 (1.55 to 3.24)
20–22 24 9 1.47 (.93 to 3.86) 1.21 (1.15 to 3.56)
Double trisomies 10 7 2.39 (.44 to 5.22) 2.26 (.56 to 5.08)
Chromosomally normal loss 157 49
Chromosomally normal live birth 226 68
a Estimates of shifts in median age at menopause, obtained from six separate analyses, each of which compared specific trisomy types
with chromosomally normal losses and births. Analyses exclude one woman with trisomy of a group E chromosome, which was not
classified more specifically.
b Excludes 28 women whose data were uninformative because they began premenopausal hormone use 11 year before the intake
interview.
c Adjusted for influence of education, ethnicity, and cigarette smoking on v1. For categories of covariates, see table 3, footnote b.
changes in circulating hormones correspond, as pre-
dicted, with changes in intraovarian hormones.
Alternatively, Warburton (1989) hypothesized that
the decrease in the number of oocytes that mature dur-
ing each cycle relates directly to nondisjunction by low-
ering the chance that an oocyte at an optimal stage of
maturation is available at ovulation. Support for this
hypothesis is found in studies of rodents whose im-
mature or postmature follicles show higher rates of non-
disjunction (Eichenlaub-Ritter 1996).
On the basis of a mathematical model linking age to
oocyte counts, trisomy, and timing of menopause, we
previously had predicted that age at menopause would
be 0.9 years earlier in women with trisomic pregnancies
(Kline and Levin 1992). Our observations meet this pre-
diction. Although we posited accelerated oocyte atresia
as the underlying common pathway to trisomy and
menopause, we cannot distinguish between this path-
way and the equally plausible hypothesis that fewer
oocytes were formed during fetal development in wom-
en who later conceived trisomic pregnancies.
Our model also predicted that shifts toward earlier
age at menopause would be more marked among wom-
en with trisomic pregnancies at older ages. Our data do
not meet this prediction: estimated shifts were larger,
although not significantly so, among women age !34
years at trisomic pregnancy than among women age
34 years at trisomic pregnancy (1.34 and 0.69 years,
respectively). If the observed shifts are taken at face
value, one or more of the assumptions in our mathe-
matical model may be incorrect, which would not be
surprising, since our model is only one of several that
might link age to oocyte counts, trisomy risk, and men-
opause onset. Inferences from these comparisons are
limited, however, because only 14% of women with
index pregnancies at younger ages had reached meno-
pause by the study’s conclusion, rendering our estimate
of the shift in median age at menopause imprecise in
this subgroup.
We also predicted larger shifts toward earlier men-
opause in women with trisomic pregnancies whose
mean maternal age was highest. Here, too, small num-
bers limit our ability either to estimate associations with
precision or to test differences between trisomy types,
but in this case our data are consistent with this pre-
diction, with the largest shifts in age at menopause ob-
served for double trisomies and trisomies of the smallest
chromosomes.
In summary, our data connect trisomic pregnancy to
earlier age at menopause. They support the hypothesis
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of a link between either depletion of the oocyte pool or
the coincident decline in the numbers of oocytes that
mature each cycle and increased risk of a trisomic
pregnancy.
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